Bill > H3947

This bill aims to enhance substance use treatment, education, and prevention efforts by implementing several key provisions. It mandates training for law enforcement officers on responding to drug overdoses and the application of relevant laws, and it removes advisory council language from certain sections of the General Laws related to alcoholism and drug rehabilitation. The bill also requires the inclusion of information on medication-assisted treatment and its availability in different regions, and it introduces a voluntary non-opiate directive form that allows individuals to state their preference against receiving opiate medications. Furthermore, it establishes stricter limits on initial opiate prescriptions, particularly for minors, and requires practitioners to document the reasons for prescribing opioids over other pain management options. The bill also mandates substance abuse evaluations for individuals experiencing opiate-related overdoses in hospitals and emergency facilities, and it requires healthcare providers to report on children's exposure to controlled substances. It also establishes a comprehensive council to oversee substance use prevention and treatment services, and it mandates that public schools develop and implement substance use prevention policies. Additionally, the bill requires healthcare providers to report on children's exposure to controlled substances and mandates substance abuse evaluations for individuals experiencing opiate-related overdoses in hospitals and emergency facilities. It also requires healthcare providers to report on children's exposure to controlled substances and mandates substance abuse evaluations for individuals experiencing opiate-related overdoses in hospitals and emergency facilities. Finally, it introduces new definitions for substance use disorders and modifies commitment procedures for individuals with such disorders, while also expanding coverage for substance abuse evaluations under various insurance plans and requiring reporting on prescription drug claims.